Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al.|Intensive Care Medicine|2021Cited by 98
Clinical Impact of Polymerase Chain Reaction–Based <i>Aspergillus</i> and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter StudySammy Huygens, Bart Rijnders, Albert Dunbar et al.|Clinical Infectious Diseases|2023Cited by 57
Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological DiseaseJochem B. Buil, Bart Rijnders, Sammy Huygens et al.|Journal of Clinical Microbiology|2023Cited by 24
The yeast genus Tardiomyces gen. nov. with one new species and two new combinationsBram Spruijtenburg, Theun de Groot, Sybren de Hoog et al.|Infection|2024Cited by 16
Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological diseaseHanne Lamberink, Bart Rijnders, Sammy Huygens et al.|Journal of Clinical Microbiology|2025Cited by 4